{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:48Z","timestamp":1792068888587,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bmcl.2026.130790","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:16:00Z","timestamp":1790781360000},"page":"130790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Uncovering the importance of lipofection for aptamer-mediated therapeutic oligonucleotide delivery in a HER2+ SKBR3 breast cancer cell line"],"prefix":"10.1016","volume":"142","author":[{"given":"Joshua","family":"O'Grady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz K.","family":"Collak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce C.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Willmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"DeRosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130790_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/genes15070903","article-title":"A comprehensive review of HER2 in cancer biology and therapeutics","volume":"15","author":"Cheng","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bmcl.2026.130790_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2026.130790_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102826","article-title":"Targeting HER2 in solid tumors: unveiling the structure and novel epitopes","volume":"130","author":"Liu","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bmcl.2026.130790_bb0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2010.04.009","article-title":"The role of HER2 in cancer therapy and targeted drug delivery","volume":"146","author":"Tai","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.bmcl.2026.130790_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021064","article-title":"Molecular targeting of the human epidermal growth factor receptor-2 (HER2) genes across various cancers","volume":"25","author":"Rubin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2026.130790_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2 \/ neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2026.130790_bb0035","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.7150\/thno.14302","article-title":"HER2 targeting peptides screening and applications in tumor imaging and drug delivery","volume":"6","author":"Geng","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.bmcl.2026.130790_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21283-3","article-title":"Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe","volume":"8","author":"Honarvar","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2026.130790_bb0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.omtn.2017.12.015","article-title":"Targeting EGFR\/HER2\/HER3 with a three-in-one aptamer-siRNA chimera confers superior activity against HER2+ breast Cancer","volume":"10","author":"Yu","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.bmcl.2026.130790_bb0050","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acs.bioconjchem.5c00022","article-title":"Targeting HER2 with DNA aptamers for efficient anticancer drug delivery: a combined experimental and computational study","volume":"36","author":"Katsuba","year":"2025","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmcl.2026.130790_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ph9020029","article-title":"Improved aptamers for the diagnosis and potential treatment of HER2-positive cancer","volume":"9","author":"Gijs","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bmcl.2026.130790_bb0060","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s12672-025-02792-w","article-title":"Identification of novel HER2 inhibitors: potential therapeutics for breast cancer","volume":"16","author":"Yalaza","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.bmcl.2026.130790_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1652","article-title":"HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors","volume":"9","author":"Spector","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmcl.2026.130790_bb0070","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1016\/j.apsb.2025.10.026","article-title":"Progress in peptide and protein therapeutics: challenges and strategies","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmcl.2026.130790_bb0075","article-title":"Small molecule inhibitors targeting the cancers","volume":"3","author":"Liu","year":"2022","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.bmcl.2026.130790_bb0080","doi-asserted-by":"crossref","unstructured":"Sun H, Zhu X, Lu PY, Rosato RR, Tan W, Zu Y. Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids 2014;3:e182. https:doi.org\/https:\/\/doi.org\/10.1038\/mtna.2014.32.","DOI":"10.1038\/mtna.2014.32"},{"key":"10.1016\/j.bmcl.2026.130790_bb0085","article-title":"Aptamers as target-specific recognition elements in drug delivery","volume":"226","author":"Vydaline","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2026.130790_bb0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0022-2836(91)90509-5","article-title":"SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis","volume":"222","author":"Irvine","year":"1991","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmcl.2026.130790_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98676-4","article-title":"Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX","volume":"11","author":"Earnest","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2026.130790_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf219","article-title":"Exploring the relationship between aptamer binding thermodynamics, affinity, and specificity","volume":"53","author":"Alkhamis","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2026.130790_bb0105","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s12094-017-1629-y","article-title":"Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas","volume":"19","author":"Sett","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.bmcl.2026.130790_bb0110","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ymthe.2025.02.047","article-title":"Using aptamers for targeted delivery of RNA therapies","volume":"33","author":"Driscoll","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.bmcl.2026.130790_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115639","article-title":"Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation","volume":"224","author":"Coppola","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2026.130790_bb0120","doi-asserted-by":"crossref","first-page":"32231","DOI":"10.1021\/acsomega.3c04345","article-title":"Recent advancements of aptamers in Cancer therapy","volume":"8","author":"Venkatesan","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2026.130790_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bmcl.2026.130790_bb0130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2010.09.007","article-title":"The critical role of GRP78 in physiologic and pathologic stress","volume":"23","author":"Pfaffenbach","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmcl.2026.130790_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc3701","article-title":"Glucose-regulated proteins in Cancer: molecular mechanisms and therapeutic potential","volume":"14","author":"Lee","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2026.130790_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/psc.70007","article-title":"Cancer-targeting peptides functionalized with polyarginine enables GRP78-dependent cell uptake and siRNA delivery within the DU145 prostate cancer cells","volume":"31","author":"Hilan","year":"2025","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bmcl.2026.130790_bb0145","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1021\/acs.nanolett.6b02274","article-title":"RNAi screening of the glucose-regulated chaperones in cancer with self-assembled siRNA nanostructures","volume":"16","author":"Patel","year":"2016","journal-title":"Nano Lett"},{"key":"10.1016\/j.bmcl.2026.130790_bb0150","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1039\/D5BM01877C","article-title":"Supramolecular RNAi with multifunctional siRNA nanostructures","volume":"14","author":"Shaikhet","year":"2026","journal-title":"Biomater Sci"},{"key":"10.1016\/j.bmcl.2026.130790_bb0155","doi-asserted-by":"crossref","unstructured":"O'Grady J, Lyu Z, Damha MJ, Sabatino D. Solid phase chemical synthesis of RNA. In: Peng, H., Kim, S.B. (eds) Biological Macromolecule Engineering Technologies. Methods Mol. Biol Humana, New York, NY; 2026, Vol. 3032:267\u2013289. https:\/\/doi. org\/https:\/\/doi.org\/10.1007\/978-1-0716-5257-2_17.","DOI":"10.1007\/978-1-0716-5257-2_17"},{"key":"10.1016\/j.bmcl.2026.130790_bb0160","article-title":"Multivalent aptamer approach: designs, strategies, and applications","volume":"13","author":"Wang","year":"2022","journal-title":"Micromachines"},{"key":"10.1016\/j.bmcl.2026.130790_bb0165","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/nar\/gkp026","article-title":"Circular dichroism and conformational polymorphism of DNA","volume":"37","author":"Kypr","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2026.130790_bb0170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/chir.22064","article-title":"Circular dichroism spectroscopy of DNA: from duplexes to Quadruplexes","volume":"24","author":"Vorl\u00ed\u010dkov\u00e1","year":"2012","journal-title":"Chirality"},{"key":"10.1016\/j.bmcl.2026.130790_bb0175","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/ja037314h","article-title":"Influences of ribonucleotide on a duplex conformation and its thermal stability: study with the chimeric RNA\u2212DNA strands","volume":"126","author":"Nakano","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2026.130790_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17460441.2024.2440095","article-title":"Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges","volume":"20","author":"Ruchi","year":"2025","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2026.130790_bb0185","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.nano.2013.05.007","article-title":"Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor","volume":"9","author":"Hsu","year":"2013","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.bmcl.2026.130790_bb0190","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/jcp.24923","article-title":"Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis","volume":"230","author":"Zhu","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bmcl.2026.130790_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2007.09.004","article-title":"Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells","volume":"468","author":"Suzuki","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bmcl.2026.130790_bb0200","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1080\/17425247.2022.2144827","article-title":"The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids","volume":"19","author":"Lau","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.bmcl.2026.130790_bb0205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41419-019-1870-0","article-title":"Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo","volume":"10","author":"Engelberg","year":"2019","journal-title":"Cell Death Dis"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600257X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600257X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:35:42Z","timestamp":1792067742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2600257X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":41,"alternative-id":["S0960894X2600257X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130790","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering the importance of lipofection for aptamer-mediated therapeutic oligonucleotide delivery in a HER2+ SKBR3 breast cancer cell line","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130790"}}